Brain health depends on genetic, lifestyle, environmental and social determinants, and its decline reduces independence and quality of life, requiring a coordinated EU‑level response. Neurological diseases are one of Europe’s most urgent and rapidly expanding health, social and economic challenges. As the population ages, neurodegenerative conditions, such as dementia (including Alzheimer’s disease), Parkinson’s disease and ALS, will rise sharply, increasing pressure on healthcare systems, social support structures and informal caregivers. The overall economic burden of these neurological disorders in Europe was estimated at EUR 368 billion per year in 2019. More than half of these costs are attributable to informal care, reflecting the significant responsibilities placed on families and communities. An ambitious coordinated, European health plan dedicated to neurological health linking prevention, early diagnosis, research, innovation to enable effective therapies, care and social support is essential to mitigate the growing impact of neurodegenerative diseases and strengthen Europe’s long‑term resilience and well‑being. Source : © European Union, 2026 - EP Read more